These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 25515669

  • 1. Pharmacodynamic studies of nitrofurantoin against common uropathogens.
    Komp Lindgren P, Klockars O, Malmberg C, Cars O.
    J Antimicrob Chemother; 2015 Apr; 70(4):1076-82. PubMed ID: 25515669
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and differential activity of nitrofurantoin against ESBL-positive pathogens involved in urinary tract infections.
    Fransen F, Melchers MJ, Meletiadis J, Mouton JW.
    J Antimicrob Chemother; 2016 Oct; 71(10):2883-9. PubMed ID: 27278898
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model.
    Maaland MG, Jakobsen L, Guardabassi L, Frimodt-Møller N.
    APMIS; 2024 Jul; 132(7):492-498. PubMed ID: 38558445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.
    Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, Kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T.
    J Infect Chemother; 2013 Jun; 19(3):393-403. PubMed ID: 23640203
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
    Jain JG, Housman ST, Nicolau DP.
    J Antimicrob Chemother; 2014 Sep; 69(9):2443-7. PubMed ID: 24827890
    [Abstract] [Full Text] [Related]

  • 11. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV, Baird AM, Karlowsky JA, Master RN, Bordon JM.
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concentration-response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faecium.
    Scheerans C, Wicha SG, Michael J, Derendorf H, Kloft C.
    Int J Antimicrob Agents; 2015 Jan 15; 45(1):54-60. PubMed ID: 25455852
    [Abstract] [Full Text] [Related]

  • 15. Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers.
    Wijma RA, Huttner A, van Dun S, Kloezen W, Abbott IJ, Muller AE, Koch BCP, Mouton JW.
    Int J Antimicrob Agents; 2019 Oct 15; 54(4):435-441. PubMed ID: 31382030
    [Abstract] [Full Text] [Related]

  • 16. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline.
    Alou L, Giménez MJ, Cafini F, Aguilar L, Sevillano D, González N, Torrico M, Prieto J, García-Rey C, García-Escribano N.
    J Antimicrob Chemother; 2009 Dec 15; 64(6):1230-3. PubMed ID: 19837715
    [Abstract] [Full Text] [Related]

  • 17. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T, Moeck G.
    J Antimicrob Chemother; 2009 Jun 15; 63(6):1191-9. PubMed ID: 19369269
    [Abstract] [Full Text] [Related]

  • 18. The Bacterial Spectrum and Antimicrobial Susceptibility in Female Recurrent Urinary Tract Infection: How Different They Are From Sporadic Single Episodes?
    Hisano M, Bruschini H, Nicodemo AC, Gomes CM, Lucon M, Srougi M.
    Urology; 2015 Sep 15; 86(3):492-7. PubMed ID: 26163810
    [Abstract] [Full Text] [Related]

  • 19. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M, Nowakowska M, Wiechuła B, Zientara M, Radosz-Komoniewska H.
    Przegl Lek; 2004 Sep 15; 61(5):473-6. PubMed ID: 15515808
    [Abstract] [Full Text] [Related]

  • 20. In-vitro activity of nitrofurantoin in enterococcus urinary tract infection.
    Butt T, Leghari MJ, Mahmood A.
    J Pak Med Assoc; 2004 Sep 15; 54(9):466-9. PubMed ID: 15518369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.